IQVIA HOLDINGS INC. Payments for Restructuring
IQVIA HOLDINGS INC. (IQV) reported Payments for Restructuring of $31.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-02-15
- IQVIA HOLDINGS INC. payments for restructuring for the quarter ending 2021-12-31 was $5.00M, a 68.75% decline year-over-year.
- IQVIA HOLDINGS INC. payments for restructuring for the quarter ending 2021-09-30 was $11.00M, a 21.43% decline year-over-year.
- IQVIA HOLDINGS INC. payments for restructuring for the quarter ending 2021-06-30 was $11.00M, a 45.00% decline year-over-year.
- IQVIA HOLDINGS INC. payments for restructuring for the quarter ending 2021-03-31 was $14.00M, a 22.22% decline year-over-year.
- IQVIA HOLDINGS INC. payments for restructuring for fiscal 2022 was $31.00M, a 24.39% decline from fiscal 2021.
- IQVIA HOLDINGS INC. payments for restructuring for fiscal 2021 was $41.00M, a 39.71% decline from fiscal 2020.
- IQVIA HOLDINGS INC. payments for restructuring for fiscal 2020 was $68.00M, a 6.85% decline from fiscal 2019.
- IQVIA HOLDINGS INC. payments for restructuring for fiscal 2019 was $73.00M, a 10.98% decline from fiscal 2018.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month | Payments for Restructuring 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $31.00M 10-K · filed 2023-02-15 | ||||
| 2021-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $16.00M derived: sum of 2 quarters · filed 2023-02-15 | $27.00M derived: sum of 3 quarters · filed 2023-02-15 | $41.00M 10-K · filed 2023-02-15 | |
| 2021-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $22.00M derived: sum of 2 quarters · filed 2021-10-22 | $36.00M 10-Q · filed 2021-10-22 | $52.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $25.00M 10-Q · filed 2021-07-28 | $41.00M derived: sum of 3 quarters · filed 2022-02-16 | $55.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-03-31 | $14.00M 10-Q · filed 2021-04-23 | $30.00M derived: sum of 2 quarters · filed 2022-02-16 | $44.00M derived: sum of 3 quarters · filed 2022-02-16 | $64.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $30.00M derived: sum of 2 quarters · filed 2022-02-16 | $50.00M derived: sum of 3 quarters · filed 2022-02-16 | $68.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $34.00M derived: sum of 2 quarters · filed 2020-10-22 | $52.00M 10-Q · filed 2020-10-22 | $70.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $38.00M 10-Q · filed 2020-07-23 | $56.00M derived: sum of 3 quarters · filed 2021-02-12 | $69.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-03-31 | $18.00M 10-Q · filed 2020-04-30 | $36.00M derived: sum of 2 quarters · filed 2021-02-12 | $49.00M derived: sum of 3 quarters · filed 2021-02-12 | $75.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $31.00M derived: sum of 2 quarters · filed 2021-02-12 | $57.00M derived: sum of 3 quarters · filed 2021-02-12 | $73.00M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $39.00M derived: sum of 2 quarters · filed 2019-11-01 | $55.00M 10-Q · filed 2019-11-01 | $73.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $42.00M 10-Q · filed 2019-07-24 | $60.00M derived: sum of 3 quarters · filed 2020-02-18 | $79.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-03-31 | $16.00M 10-Q · filed 2019-05-02 | $34.00M derived: sum of 2 quarters · filed 2020-02-18 | $53.00M derived: sum of 3 quarters · filed 2020-02-18 | $74.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $37.00M derived: sum of 2 quarters · filed 2020-02-18 | $58.00M derived: sum of 3 quarters · filed 2020-02-18 | $82.00M 10-K · filed 2020-02-18 | |
| 2018-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $40.00M derived: sum of 2 quarters · filed 2018-10-25 | $64.00M 10-Q · filed 2018-10-25 | $83.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $45.00M 10-Q · filed 2018-07-27 | $64.00M derived: sum of 3 quarters · filed 2019-02-19 | $84.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-03-31 | $24.00M 10-Q · filed 2018-05-04 | $43.00M derived: sum of 2 quarters · filed 2019-02-19 | $63.00M derived: sum of 3 quarters · filed 2019-02-19 | $84.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $39.00M derived: sum of 2 quarters · filed 2019-02-19 | $60.00M derived: sum of 3 quarters · filed 2019-02-19 | $81.00M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $41.00M derived: sum of 2 quarters · filed 2017-10-27 | $62.00M 10-Q · filed 2017-10-27 | $86.92M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2017-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $42.00M 10-Q · filed 2017-08-04 | $66.92M derived: sum of 3 quarters · filed 2018-02-16 | $82.33M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2017-03-31 | $21.00M 10-Q · filed 2017-05-08 | $45.92M derived: sum of 2 quarters · filed 2018-02-16 | $61.33M derived: sum of 3 quarters · filed 2018-02-16 | $68.41M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-12-31 | $24.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $40.33M derived: sum of 2 quarters · filed 2018-02-16 | $47.41M derived: sum of 3 quarters · filed 2018-02-16 | $50.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $15.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $22.48M derived: sum of 2 quarters · filed 2016-11-03 | $25.08M 10-Q · filed 2016-11-03 | $33.27M derived: sum of 4 quarters · filed 2017-02-16 | |
| 2016-06-30 | $7.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $9.67M 10-Q · filed 2016-07-27 | $17.87M derived: sum of 3 quarters · filed 2017-02-16 | $22.85M derived: sum of 4 quarters · filed 2017-02-16 | |
| 2016-03-31 | $2.59M 10-Q · filed 2016-05-03 | $10.79M derived: sum of 2 quarters · filed 2017-02-16 | $15.77M derived: sum of 3 quarters · filed 2017-02-16 | $22.31M derived: sum of 4 quarters · filed 2017-02-16 | |
| 2015-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $13.18M derived: sum of 2 quarters · filed 2017-02-16 | $19.71M derived: sum of 3 quarters · filed 2017-02-16 | $24.00M 10-K · filed 2017-02-16 | $23.67M 10-K · filed 2016-02-11 |
| 2015-09-30 | $4.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $11.52M derived: sum of 2 quarters · filed 2015-10-28 | $15.81M 10-Q · filed 2015-10-28 | $18.37M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2015-06-30 | $6.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $10.82M 10-Q · filed 2015-07-29 | $13.39M derived: sum of 3 quarters · filed 2016-02-11 | $14.58M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2015-03-31 | $4.29M 10-Q · filed 2015-04-29 | $6.85M derived: sum of 2 quarters · filed 2016-02-11 | $8.04M derived: sum of 3 quarters · filed 2016-02-11 | $9.74M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $3.75M derived: sum of 2 quarters · filed 2016-02-11 | $5.46M derived: sum of 3 quarters · filed 2016-02-11 | $8.16M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $2.90M derived: sum of 2 quarters · filed 2014-10-30 | $5.59M 10-Q · filed 2014-10-30 | ||
| 2014-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $4.40M 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | $2.70M 10-Q · filed 2014-05-01 | ||||
| 2013-12-31 | $21.48M 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |